Our Nectin-4 NDC effectively inhibited gastric cancer growth in vivo in a dose-dependent manner, indicating its potential as an effective anti-tumor agent for gastric cancer and other Nectin-4-positive tumors. This evidence concerns the gene NECTIN4 and gastric cancer.